Penumbra (PEN)
(Real Time Quote from BATS)
$178.37 USD
+0.38 (0.21%)
Updated Jul 10, 2024 11:24 AM ET
2-Buy of 5 2
C Value A Growth F Momentum C VGM
Price, Consensus and EPS Surprise
PEN 178.37 +0.38(0.21%)
Will PEN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for PEN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PEN
Here's Why Holding Align Technology (ALGN) Stock Could Pay Off
Why Penumbra (PEN) is a Top Growth Stock for the Long-Term
PEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Penumbra (PEN) is a Top Growth Stock for the Long-Term
Why Is Penumbra (PEN) Down 4.8% Since Last Earnings Report?
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Other News for PEN
UK shareholder meetings calendar - next 7 days
Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024
Pennant International Schedules AGM, Eyes Growth
Penumbra (PEN) Gets a Buy from RBC Capital
Top 3 Health Care Stocks That Could Blast Off In June